Loading
RT
Repros Therapeutics Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by PODOLSKI JOSEPH, was filed 09 Dec 2016.
Repros Therapeutics Inc.: what insiders have been doing
Repros Therapeutics Inc. is a listed company. Its directors and officers file their transactions with SEC (Form 4). The past year has been quiet: not a single insider filing for Repros Therapeutics Inc. The previous disclosure was published on 31 January 2018.
Our records for Repros Therapeutics Inc. go back to 2016, with 8 purchases and 1 sale on the open market in total.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Insider Decl.
31
Thresholds
n/a
Buy Volume
€73,540
8 ops. · all time
Sell Volume
€6,089
1 ops. · all time
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2016FY ended December 2016 · cache
Income statement
Revenue41.9k
Net income-15.4M-36751.1% margin
Last declaration on 31 January 2018
Declarations31 total
23,221 shares@ US$0.6745.5% of flowCommon StockSEC:0001144204-18-004779:0
27,779 shares@ US$0.6754.5% of flowCommon StockSEC:0001144204-18-004779:1
21,580 shares@ US$0.6743.7% of flowCommon StockSEC:0001144204-18-004789:0
27,779 shares@ US$0.6756.3% of flowCommon StockSEC:0001144204-18-004789:1
12,221 shares@ US$0.6730.5% of flowCommon StockSEC:0001144204-18-004784:0
27,779 shares@ US$0.6769.5% of flowCommon StockSEC:0001144204-18-004784:1
83,875 shares@ US$0.6779.1% of flowCommon StockSEC:0001144204-18-004777:0
12,221 shares@ US$0.6723.8% of flowCommon StockSEC:0001144204-18-004781:0
27,779 shares@ US$0.6754.2% of flowCommon StockSEC:0001144204-18-004781:1
12,221 shares@ US$0.6730.5% of flowCommon StockSEC:0001144204-18-004787:0
27,779 shares@ US$0.6769.5% of flowCommon StockSEC:0001144204-18-004787:1
10,000 sharesCommon StockSEC:0001144204-17-035636:0
10,000 sharesCommon StockSEC:0001144204-17-030841:0
10,000 sharesCommon StockSEC:0001144204-17-023631:0
10,000 sharesCommon StockSEC:0001144204-17-018857:0
10,000 sharesCommon StockSEC:0001144204-17-012515:0
40,000 sharesCommon StockSEC:0001144204-17-009369:0
40,000 sharesCommon StockSEC:0001144204-17-009373:0
40,000 sharesCommon StockSEC:0001144204-17-009366:0
40,000 sharesCommon StockSEC:0001144204-17-009375:0
40,000 sharesCommon StockSEC:0001144204-17-009364:0
10,000 sharesCommon StockSEC:0001144204-17-005935:0
20,000 shares@ US$1.6058.7% of flowCommon StockSEC:0001144204-16-138799:0
Canonical exit: 9 Mar 2017 (T+90)
3,305 shares@ US$1.9522.0% of flowCommon StockSEC:0001144204-16-136348:0
10,000 shares@ US$0.9316.3% of flowCommon StockSEC:0001144204-16-083401:0
Canonical exit: 18 May 2016 (T+90)
25 of 31 declarations
About Repros Therapeutics Inc.
Repros Therapeutics Inc. is a biopharmaceutical company focused on developing treatments for hormonal and reproductive disorders. It is listed on NASDAQ under the ticker RPRX.
